OPX Biotechnologies Inc. (OPX; Boulder, Colo.; www.opxbio.com) today announced that the company has successfully demonstrated its fermentation process for bio-based acrylic acid at the 3,000-L scale.
OPX is working with The Dow Chemical Co. (Midland, Mich.; www.dow.com) to bring its bio-based acrylic acid, known as BioAcrylic, into the $10-billion market for acrylic used in products such as diapers, detergents, paints and adhesives.
OPX worked with the Michigan Biotechnology Institute (MBI; Lansing, Mich.; www.mbi.org) to successfully scale up its BioAcrylic fermentation process to 3,000 liters.
The not-for-profit MBI helps companies de-risk and scale-up bio-based technologies. OPX has developed a proprietary technology called EDGE (efficiency-directed genome engineering) to manufacture renewable bio-based chemicals and fuels that are more economical and sustainable than petroleum-based products.